Before you sell to, join or invest in Octave Bioscience Inc
MentionFox check on Octave Bioscience Inc: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/octave-bioscience-inc-form-d-25000001
Check Octave Bioscience Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Octave Bioscience Inc?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Octave Bioscience Inc filed a Form D with the Securities and Exchange Commission on 2025-03-24.
Octave Bioscience Inc filed a Form D notice of an exempt securities offering with the SEC on March 24, 2025. The filing reports $31.84M sold. Its industry group is Other Health Care. It names William Hagstrom (Director), Doug Biehn (Executive Officer, Director), Brook Byers (Director) (SEC Form D, March 24, 2025).
Is this your company?
Sell to companies like Octave Bioscience Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Octave Bioscience Inc.
Free to see. No signup.
More on the people and the money behind Octave Bioscience Inc, from the filings we hold.
Other Health Care raises by companies based in California, filed in March 2025, largest first.
Get an email when Octave Bioscience Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Octave Bioscience Inc raises, hires or launches. No email unless you switch it on.
Watch Octave Bioscience Inc →Get the full cited report on Octave Bioscience Inc
What the filing shows about Octave Bioscience Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Octave Bioscience Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Octave Bioscience Inc's address as 1440 O'Brien Drive, Suite B, Menlo Park, CA 94025.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Octave Bioscience Inc is a registered filer with the SEC (CIK 1702278) and has filed since 2023-11-24. 3 filings are on record, the latest on 2025-03-24.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Octave Bioscience Inc's Form D of 2025-03-24 names William Hagstrom, Doug Biehn, Brook Byers and 6 more as its officers, directors or promoters.
Its new offerings report $71.34M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
William Hagstrom is named as Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
Doug Biehn is named as Executive Officer and Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
Brook Byers is named as Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
Thomas Hawes is named as Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
A. Grant Heidrich III is named as Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
Lucy Coassin is named as Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
Michael Pellini is named as Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
George Scangos is named as Director on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
Marcel Konrad is named as Executive Officer on the Form D that Octave Bioscience Inc filed with the SEC on 24 March 2025, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2025-03-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Octave Bioscience Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Octave Bioscience Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Octave Bioscience Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Octave Bioscience IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Octave Bioscience Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Octave Bioscience Inc. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/octave-bioscience-inc-form-d-25000001